Canada markets open in 1 hour 32 minutes
  • S&P/TSX

    19,556.15
    -244.46 (-1.23%)
     
  • S&P 500

    4,273.53
    -63.91 (-1.47%)
     
  • DOW

    33,618.88
    -388.00 (-1.14%)
     
  • CAD/USD

    0.7390
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    92.19
    +1.80 (+1.99%)
     
  • Bitcoin CAD

    36,214.79
    +712.46 (+2.01%)
     
  • CMC Crypto 200

    573.70
    +9.88 (+1.75%)
     
  • GOLD FUTURES

    1,911.70
    -8.10 (-0.42%)
     
  • RUSSELL 2000

    1,761.61
    -22.63 (-1.27%)
     
  • 10-Yr Bond

    4.5580
    0.0000 (0.00%)
     
  • NASDAQ futures

    14,755.00
    +40.00 (+0.27%)
     
  • VOLATILITY

    18.26
    -0.68 (-3.59%)
     
  • FTSE

    7,615.44
    -10.28 (-0.13%)
     
  • NIKKEI 225

    32,371.90
    +56.85 (+0.18%)
     
  • CAD/EUR

    0.7007
    +0.0013 (+0.19%)
     

Delta 9 Awarded Grow Pod Contract for Cultivation Facility in British Columbia

Delta 9 Cannabis
Delta 9 Cannabis

WINNIPEG, Manitoba, May 10, 2023 (GLOBE NEWSWIRE) --  DELTA 9 CANNABIS INC. (TSX:DN) (OTCQX:DLTNF) (“Delta 9” or the “Company”) is pleased to announce that it has secured a purchase order from 1356089 BC Ltd. for up to 12 of its modular Grow Pods for a cultivation facility in British Columbia.

1356089 BC Ltd. has also entered into a Strategic Cooperation Agreement with the Company whereby Delta 9 will provide services relating to 1356089 BC Ltd.’s cannabis production facility, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, marketing services to develop the 1356089 BC Ltd. brand, and other services supporting the acquisition of a Health Canada cultivation and processing license. The Company anticipates the value of the purchase order and Strategic Cooperation Agreement will be approximately $1.2 million.

“We are delighted to partner with 1356089 BC Ltd. on the development of their facility which will house twelve of our proprietary and turn-key "Grow Pod" systems”, said John Arbuthnot, Founder and CEO of Delta 9. “Our turnkey platform for Grow Pods and services continues to prove one of the best options for cannabis industry entrepreneurs seeking licensing and support services as they launch their businesses.”

The Company's cannabis production methodology is based around a modular, scalable, and stackable production unit called a "Grow Pod", which are based on retrofitted 40-foot shipping containers. 1356089 BC Ltd. production facility has been designed and purpose built using this turnkey and state of the art Grow Pod system. Since 2018 Delta 9 has successfully installed over 250 Grow Pods in third party facilities across Canada and the United States.

“1356089 BC Ltd. is a business partnership and self-funded cannabis grower based in Merit, British Columbia. We have plans to service the recreational cannabis market in BC and across Canada.” said the 1356089 BC Ltd. management team. “We are confident in our ability to produce premium BC grown cannabis products that will delight Canadian consumers.”

1356089 BC Ltd. is developing a state-of-the-art 4800 sq ft micro cultivation facility on a 4-acre parcel of land, in Merit, British Columbia. This new facility houses a micro cultivation license, including twelve new grow pod systems, and a proprietary craft growing approach developed by Delta 9. 1356089 BC Ltd.’s initial plan is to focus on growing two strains of 25%+ THC before it expands its product offering. 1356089 BC Ltd. owns two additional half-acre adjacent lots to the property which are slated for future expansion of 18,000 sq ft to house an additional 48 Grow Pods.

For more information contact:

Investor & Media Contact:
Ian Chadsey VP Corporate Affairs
Mobile: 204-898-7722
E-mail: ian.chadsey@delta9.ca

About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 95,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "DLTNF". For more information, please visit www.delta9.ca.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include (i) statements relating to the Company’s plans to supply Grow Pods to 1356089 BC Ltd., (ii) the Company’s plans to provide services to 1356089 BC Ltd. and (iii) the Company’s ability to realize revenue from the sale of Grow Pods and provision of services. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including all risk factors set forth in the annual information form of Delta 9 dated March 31, 2023 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.